Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NL-OMON40149
NL-OMON40149CompletedNot Applicable

A multicentre Prospective study in pAtients undergoing ventral herNia repair by open approach with intrA-peritoneal positioning using parietex* Composite vEntral pAtch. - PANACEA-trial

Covidien0 sites8 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Covidien
Enrollment
8
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

Trial is onging in other countries

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • •primary ventral hernia
  • •maximum hernia size 4 cm

Exclusion Criteria

  • •emergency procedure
  • •pregnancy known/suspected/planned during study follow-up period

Investigators

Sponsor
Covidien

Similar Trials

Completed
Not Applicable
A prospective, multi-centre study investigating the incidence and prognosis of relapses, pseudo-relapses and other causes of (sub)acute neurological symptoms in patients with relapsing-remitting multiple sclerosis.Multiple sclerosis
NL-OMON55562Sint Elisabeth Ziekenhuis125
Completed
Not Applicable
Multicenter randomized clinical trial in Patients with Juvenile Idiopathic Arthritis and Methotrexate related side effects: Psychological Behavioural therapy versus switch to MTX parenteral versus standard of careJuvenile Idiopathic Arthritis
NL-OMON38373niversitair Medisch Centrum Utrecht450
Completed
Phase 4
A prospective randomised controlled multicentre trial comparing half-dose photodynamic therapy (PDT) with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (CSC).Chronic central serous chorioretinopathy10047060
NL-OMON39842niversitair Medisch Centrum119
Completed
Phase 4
A Prospective, Randomized, Multi-center Study to Assess the SaFety of the Orsiro Mission Stent compared to the ResoLute Onyx Stent in Subjects at High Risk for Bleeding in combination With 1-month Dual Antiplatelet Therapy (DAPT).
NL-OMON52323BIOTRONIK AG1
Completed
Phase 3
Prospective multicenter clinical trial with the PRECIZION Presbyopic multifocal intraocular lens10047518CataractPresbyopia
NL-OMON41971OPHTEC BV10